StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
372910.KS$2005.00+0.45%
Fair $2005.00+0.0%

372910.KS

Hancom Lifecare Inc.

Technology / Software - ApplicationKSE

$2005.00

+9.00 (+0.45%)

Fairly Valued+0.0%Fair Value $2005.00Fund rank 25/100 · Data gapFallback financials|
SA 18/F
F-Score: 3/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $16.8B · quality 43.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

18/100

F

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is -6.1%, below the 5% threshold
Thesis & Journal · 372910.KSLocal privado en este navegador · Hancom Lifecare Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$55.5B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-6.1%

↓

Gross Margin

23.3%

↓

Debt/Equity

0.00

↓
52-Week Range$2005
$1950$3780

TradingView lightweight chart

372910.KS price, volumen y niveles de valoración

Último $2,005Periodo -84.3%
Fair value: $2,005

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-2.7%

FCF CAGR

—

FCF margin

18.2%

FCF / Net income

-2.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $92.09B · net income $-7.73B · FCF $16.75B

2022-FY → 2025-FY

Gross margin

23.3%+3.4% pts

Operating margin

-0.7%+0.6% pts

Net margin

-8.4%-17.6% pts

FCF margin

18.2%+19.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$92.09B$92.09B$104.78B$112.78B$100.12B
Net Income$-7.73B$-7.73B$7.37B$824.7M$9.20B
EBITDA$-4.57B$-4.57B$14.72B$8.89B$20.59B
EPS-279.00-279.00266.0030.00333.00
Gross Margin23.3%23.3%27.8%21.0%19.9%
Operating Margin-0.7%-0.7%7.1%1.6%-1.3%
Net Margin-8.4%-8.4%7.0%0.7%9.2%
Balance Sheet
Debt/Equity0.000.000.000.010.03
Current Ratio1.611.61———
Cash Flow
Free Cash Flow$16.75B$16.75B$17.91B$-13.82B$-1.06B
Returns
ROE-6.1%-6.1%5.5%0.6%7.2%
Valuation
P/E——12.26157.3318.47
EV/EBITDA——3.8412.855.64
P/B0.440.440.671.021.34
Growth & Yield
Revenue Growth-12.1%-12.1%-7.1%12.6%—
EPS Growth-204.9%-204.9%786.7%-91.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -29.8%

Total return

-29.8%

Start / end P/E

n/dx → n/dx

EPS bridge

266.00 → -279.00

Residual

-29.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-29.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.